The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders.
Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet
Related Posts
Crypto user pleads guilty after spending $10m deposit error
A crypto investor who received over $10 million instead of a $100 deposit is facing jail time after…
Post-Christmas miracle as Bitcoin ETFs clinch inflow after 4-day bleed
US spot Bitcoin ETFs notched a positive net inflow after four trading days that bled over $1.5 billion.
Seamless soars 31% in first day on Coinbase
Seamless Protocol’s governance token, SEAM, saw significant gains during its first day of trading, rising over 31% from…
